Novel, dynamic on-line analytical separation system for dissolution of drugs from poly(lactic acid) nanoparticles

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 1, 2010, Pages 125-130

  Helle, Anne ^a   Hirsjärvi, Samuli ^a   Peltonen, Leena ^a   Hirvonen, Jouni ^a   Wiedmer, Susanne K ^a   Hyötyläinen, Tuulia ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Beclomethasone dipropionate; Dissolution; Drug release; Indomethacin; Liquid chromatography; Poly(lactic acid)

Indexed keywords

BECLOMETASONE DIPROPIONATE; INDOMETACIN; NANOPARTICLE; POLYLACTIC ACID; PURASORB; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG SOLUBILITY; LIQUID CHROMATOGRAPHY; NANOENCAPSULATION; ONLINE ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; TEMPERATURE DEPENDENCE;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BECLOMETHASONE; CHROMATOGRAPHY, LIQUID; DRUG CARRIERS; INDOMETHACIN; LACTIC ACID; NANOPARTICLES; POLYMERS; SOLUBILITY; SOLVENTS; TEMPERATURE;

EID: 70349319347     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.08.021     Document Type: Article

References (19)

1. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., and Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70 (2001) 1-20
2. Leroux J.-C., Allémann E., De Jaeghere F., Doelker E., and Gurny R. Biodegradable nanoparticles-from sustained release formulations to improved site specific drug delivery. J. Control. Release 39 (1996) 339-350
3. Kawashima Y., Yamamoto H., Takeuchi H., Hino T., and Niwa T. Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur. J. Pharm. Biopharm. 45 (1998) 41-48
4. Tobío R.G.R., Sánchez A., Langer R., and Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15 (1998) 270-275
5. Ferranti V., Marchais H., Chabenat C., Orecchioni A.M., and Lafont O. Primidone-loaded poly-[var epsilon]-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles. Int. J. Pharm. 193 (1999) 107-111
6. Bocolo C., Giannavola C., Maltese A., Paolino D., Vandelli M.A., Puglisi G., Lee V.H.L., and Fresta M. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of peg coating on ocular drug bioavailability. Pharm. Res. 20 (2003) 584-590
7. Redhead H.M., Davis S.S., and Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release 70 (2001) 353-363
8. Govender T., Stolnik S., Garnett M.C., Illum L., and Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 57 (1999) 171-185
9. Ahlin P., Kristl J., Kristl A., and Vrecer F. Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration. Int. J. Pharm. 239 (2002) 113-120
10. Leroueil-Le Verger M., Fluckiger L., Kim Y.-I., Hoffman M., and Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46 (1998) 137-143
11. Alvarez-Román R., Barré G., Guy R.H., and Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur. J. Pharm. Biopharm. 52 (2001) 191-195
12. Leo E., Brina B., Forni F., and Vandelli M.A. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form. Int. J. Pharm. 278 (2004) 133-141
13. Santos Magalhaes H.F.N.S., Puisieux F., Benita S., and Seiller M. An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride. J. Microencapsul. 12 (1995) 195-205
14. De Campos A.M., Sánchez A., Gref R., Calvo P., and Alonso M.J. The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur. J. Pharm. Sci. 20 (2003) 73-81
15. Teixeira M., Alonso M.J., Pinto M.M.M., and Barbosa C.M. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur. J. Pharm. Biopharm. 59 (2005) 491-500
16. Niwa T., Takeuchi H., Hino T., Kunou N., and Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release 25 (1993) 89-98
17. Zhu Z., Grazia Cascone M., Borselli F., and Lazzeri L. Poly(vinyl alcohol) hydrogels as hydrophilic matrices for the release of lipophilic drugs loaded in PLGA nanoparticles. J. Mater. Sci.: Mater. Med. 13 (2002) 29-32
18. Helle A., Hirsjärvi S., Peltonen L., Hirvonen J., and Wiedmer S.K. Quantitative determination of drug encapsulation in poly(lactic acid) nanoparticles by capillary electrophoresis. J. Chromatogr. A 1178 (2008) 248-255
19. Fessi H., Puisieux F., Devissaguet J.P., Ammoury N., and Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55 (1989) R1-R4